Junkai Yao

Junkai Yao

Auto-generated profile, based on publicly available information

Junkai Yao

Beijing University of Chinese Medicine, Beijing 100029, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JYJunkai Yao
Junkai Yao
YDYunfeng Di
Yunfeng Di
CWChao Yong Wu
Chao Yong Wu
LZLu Zhou
Lu Zhou
MSMingyan Shao
Mingyan Shao
WWWei Wang
Wei Wang
Background: Gamabufotalin (Ga) is a primary bioactive bufadienolide extracted from Venenum Bufonis. It has been identified to exert anti-fibrotic and anti-inflammatory properties; however, its anti-fibrotic effect and underlying mechanism in heart failure (HF) remain undetermined.Purpose: This study aimed to evaluate the cardioprotective and anti-fibrotic properties of Ga in LADL-induced HF rats and isoproterenol (ISO)-induced HF mice. Furthermore, the molecular target and signaling mechanisms associated with Ga were investigated.Methods: In vivo cardiac function and fibrosis rate were assessed by echocardiography, histopathology, and Western blotting. For in vitro analysis, primary cardiac fibroblasts (CFs) were first stimulated with TGF-β1 and then evaluated for proliferation and migration using CCK-8, EdU, wound healing, and Transwell assays. Molecular docking and rescue assays were carried out using the TGFBR1 agonist SRI. Moreover, a Smad2/3 nuclear translocation assay was performed to identify the key target and mechanism.Results: The data revealed that Ga significantly improved cardiac function, alleviated myocardial hypertrophy and fibrosis, and inhibited activation of TGFBR1/Smad signaling in two HF models. In vitro, Ga (20 nM) inhibited TGF-β1-induced CF proliferation and migration, decreased Smad2/3 phosphorylation and nuclear translocation, and downregulated fibrotic markers. Ga directly targeted TGFBR1, whereas its anti-fibrotic effects were reversed by SRI-mediated TGFBR1 activation.Conclusion: This study revealed that Ga alleviates myocardial fibrosis and improves heart function by directly suppressing TGFBR1 and blocking downstream Smad2/3 signaling. These results suggest that Ga could serve as an anti-fibrotic agent for HF and provide pharmacological evidence for the modern application of toad venom–derived compounds.

10 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YWYuqi Wang
Yuqi Wang
WDWenqing Dong
Wenqing Dong
JYJunkai Yao
Junkai Yao
KWKai Wang
Kai Wang
LZLeyuan Zhang
Leyuan Zhang
YLYu Li
Yu Li
Network pharmacology has become a widely used approach for deciphering multi-component, multi-target mechanisms of traditional Chinese medicine (TCM). Here we introduce TCMCard, a high-confidence digital infrastructure built on a Multi-Dimensional Evidence Integration (MDEI) framework. The framework integrates experimental activity data from authoritative chemical databases, literature-derived evidence, and structure-based similarity inference. Preprocessing steps include chemical structure normalization, species-specific filtering, and target quality scoring. Applied to conventional interaction datasets, this pipeline leads to the removal of over 60% of low-confidence noise. TCMCard supports network pharmacology exploration through an interactive visualization platform, and module analysis identifies functionally relevant communities that offer insights into the synergistic actions of TCM formulas. Overall, TCMCard may help move the field beyond simple data aggregation toward evidence-informed curation and quality-driven analysis. As an interactive and publicly accessible platform, it reveals an organized backbone within complex interaction networks, offering a more reliable basis for understanding multi-component synergy in TCM.